🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/12/2008 | 8,61 | 9,51 | 8,38 | 9,47 | +13,45% | 13,04% | 78.921 |
| 15/12/2008 | 8,76 | 8,91 | 7,64 | 8,35 | -3,88% | 14,53% | 56.479 |
| 12/12/2008 | 7,49 | 8,76 | 7,41 | 8,68 | +12,08% | 18,00% | 73.311 |
| 11/12/2008 | 9,36 | 9,54 | 7,67 | 7,75 | -18,82% | 20,00% | 82.848 |
| 10/12/2008 | 9,36 | 9,73 | 8,83 | 9,54 | +4,08% | 9,60% | 53.433 |
| 09/12/2008 | 8,98 | 10,07 | 8,61 | 9,17 | -1,61% | 16,25% | 138.232 |
| 08/12/2008 | 8,23 | 9,32 | 8,05 | 9,32 | +17,45% | 15,45% | 114.882 |
| 05/12/2008 | 7,49 | 7,94 | 7,26 | 7,94 | +3,92% | 9,00% | 71.227 |
| 04/12/2008 | 7,41 | 7,79 | 7,22 | 7,64 | +1,49% | 7,58% | 68.876 |
| 03/12/2008 | 7,22 | 8,16 | 7,15 | 7,52 | +2,03% | 13,99% | 88.833 |
| 02/12/2008 | 7,19 | 7,41 | 7,00 | 7,37 | +5,92% | 5,73% | 122.977 |
| 01/12/2008 | 7,41 | 7,60 | 6,77 | 6,96 | -9,71% | 11,11% | 77.558 |
| 28/11/2008 | 7,45 | 7,75 | 6,74 | 7,71 | +4,04% | 13,57% | 128.561 |
| 26/11/2008 | 6,70 | 7,64 | 6,66 | 7,41 | +5,88% | 14,53% | 507.937 |
| 25/11/2008 | 7,41 | 7,41 | 6,33 | 7,00 | -8,33% | 14,65% | 202.993 |
| 24/11/2008 | 7,71 | 7,86 | 7,11 | 7,64 | +2,00% | 9,71% | 179.937 |
| 21/11/2008 | 6,55 | 7,52 | 6,29 | 7,49 | +50,38% | 18,86% | 343.122 |
| 20/11/2008 | 4,90 | 5,24 | 4,57 | 4,98 | +4,72% | 13,74% | 109.752 |
| 19/11/2008 | 5,24 | 5,39 | 4,75 | 4,75 | -9,29% | 12,14% | 51.884 |
| 18/11/2008 | 5,32 | 5,39 | 5,05 | 5,24 | -0,71% | 6,34% | 69.731 |
| 17/11/2008 | 5,05 | 5,39 | 4,90 | 5,28 | +3,68% | 9,63% | 62.277 |
| 14/11/2008 | 5,46 | 6,03 | 5,02 | 5,09 | -5,55% | 18,49% | 127.599 |
| 13/11/2008 | 5,17 | 5,61 | 4,83 | 5,39 | +5,88% | 15,22% | 783.760 |
| 12/11/2008 | 5,02 | 5,43 | 4,90 | 5,09 | +0,00% | 10,45% | 86.268 |
| 11/11/2008 | 5,20 | 5,61 | 4,87 | 5,09 | +0,74% | 14,39% | 136.282 |
| 10/11/2008 | 5,69 | 5,91 | 4,38 | 5,05 | -7,54% | 26,97% | 209.966 |
| 07/11/2008 | 5,28 | 5,76 | 4,64 | 5,46 | +3,55% | 21,28% | 123.805 |
| 06/11/2008 | 5,65 | 5,95 | 5,17 | 5,28 | -4,08% | 13,91% | 441.012 |
| 05/11/2008 | 6,96 | 7,52 | 5,17 | 5,50 | -22,63% | 33,87% | 488.915 |
| 04/11/2008 | 8,01 | 8,01 | 6,44 | 7,11 | -0,52% | 19,63% | 144.217 |